Cyclic nucleotides in experimental and human brain tumors

Area of Science:

• Neuroscience
• Oncology
• Biochemistry

Background:

• Cyclic nucleotides, including cyclic AMP (cAMP) and cyclic GMP (cGMP), are crucial for cell differentiation and proliferation.
• Understanding their role in brain tumor development is essential for identifying early cellular transformations.

Purpose of the Study:

• To investigate the changes in adenylcyclase (AC) activity and cGMP content during the latency period and early stages of experimentally induced brain tumors.
• To analyze AC activity and cAMP levels in human brain tumors and cerebrospinal fluid.

Main Methods:

• Induction of brain tumors in rats using ethylnitrosourea (ENU) via transplacental exposure.
• Measurement of adenylcyclase activity and cGMP levels in rat brain tissue at various time points.
• Assay of AC activity and cAMP levels in human tumoral tissues and cerebrospinal fluid.

Main Results:

• In ENU-treated rats, AC activity decreased significantly by day 60, while cGMP levels remained elevated compared to controls.
• Experimental brain tumors showed a marked reduction in AC activity.
• Human malignant brain tumors exhibited lower AC activity than benign tumors, with similar cAMP levels observed in cerebrospinal fluid.

Conclusions:

• The cyclic nucleotide system is involved in all phases of brain tumor development, from initial transformation to fully developed tumors.
• Alterations in AC activity and cGMP levels may serve as biomarkers for brain tumor progression.
• These findings offer insights into the early molecular changes underlying tumoral cell transformation.